FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors


Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22015013367405/14/15Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
32015008763203/26/15Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as jak inhibitors
42015008766203/26/15Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
52015006544703/05/15Survival benefit in patients with solid tumors with elevated c-reactive protein levels
62015006548403/05/15Sustained release dosage forms for a jak1 inhibitor
72015005726502/26/15Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
82015002505601/22/15Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
92015001717301/15/15Antibodies to human transmembrane proteins
102015001154001/08/15Tricyclic heterocycles as bet protein inhibitors
112015000416501/01/15Secreted proteins
122014037729212/25/14Modulators of indoleamine 2,3-dioxygenase and methods of using the same
132014037840012/25/14Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
142014037121612/18/14Purinone derivatives as hm74a agonists
152014034303011/20/14Bipyrazole derivatives as jak inhibitors
162014031596210/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
172014027503009/18/14Tricyclic heterocycles as bet protein inhibitors
182014027503109/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
192014027512709/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
202014025694109/11/14Processes and intermediates for making a jak inhibitor
212014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
222014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
232014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
242014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
252014022727508/14/14Methods of treating and diagnosing pancreatitis
262014022727808/14/14Antibodies to human signal peptide-containing proteins
272014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
282014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
292014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
302014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
312014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
322014017140506/19/14Fused pyrazoles as fgfr inhibitors
332014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
342014015528806/05/14Methods for diagnosing cancer
352014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
362014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
372014013535005/15/14Sustained-release dosage forms of ruxolitinib
382014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
392014012122205/01/14Pyrimidinones as pi3k inhibitors
402014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
412014005690602/27/14Secreted proteins
422014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
432014004581402/13/14Pyrazine derivatives as fgfr inhibitors
442014003134401/30/14Azepine inhibitors of janus kinases
452014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
462014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
472014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
482014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
492013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
502013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
512013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
522013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
532013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
542013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
552013024378109/19/13Signal peptide-containing proteins
562013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
572013024499909/19/13Substituted heterocyclic compounds
582013022476908/29/13Methods of using chemokine panec-1 antibodies
592013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
602013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
612013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
622013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
632013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
642013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
652013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
662013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
672013005983503/07/13Heterocyclylamines as pi3k inhibitors
682013006002603/07/13Processes and intermediates for making a jak inhibitor
692013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
702013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
712013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
722012032978212/27/12Azepine inhibitors of janus kinases
732012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
742012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
752012027080910/25/12Human transmembrane proteins
762012012285805/17/12Lactam compounds and their use as pharmaceuticals
772012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
782012003517202/09/12Purinone derivatives as hm74a agonists
792012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
802012001592801/19/12Amido compounds and their use as pharmaceuticals
812011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
822011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
832011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
842011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
852011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
862011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
872011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
882010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
892010025611410/07/10Amido compounds and their use as pharmaceuticals
902010024067109/23/10Substituted heterocyclic compounds
912010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
922010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
932010017390107/08/10Substituted heterocyclic compounds
942010013740106/03/102-methylprop anamides and their use as pharmaceuticals
952010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
962010009961704/22/10Secreted proteins
972009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
982009029194611/26/09Lactam compounds and their use as pharmaceuticals
992009028677411/19/09Purinone derivatives as hm74a agonists
1002009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
1012009027468011/05/09Human phospholipases
1022009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
1032009021576608/27/09Tetracyclic inhibitors of janus kinases
1042009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
1052009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1062009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
1072009008844604/02/09Purinone derivatives as hm74a agonists
1082009007626903/19/09Purinone derivatives as hm74a agonists
1092012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
1102012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
1112012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1122011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1132011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1142011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1152011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1162011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1172011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1182009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1192009019786908/06/09Azepine inhibitors of janus kinases



ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE